Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups, respectively.

The medication names of the current FDA-approved topical agents for the treatment of AK including Carac® (Sanofi-Aventis, NJ, USA), Efudex® (Valeant, CA, USA) and Fluoroplex® (Allergan ...